http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_afbeb2fc7bc541ab09f1abbbe31c1582
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Hulthe |
| name | Johannes Hulthe |
| given-name | Johannes |
| organization-name | From the Department of Medicine, Sahlgrenska University Hospital/Sahlgrenska, Gothenburg (S.A., B.F.), the Department of Clinical Microbiology, Gävle Central Hospital, Gävle (H.G., J.G.), Institute of Medical Sciences, University of Uppsala, Uppsala (H.G.), and the Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska University Hospital/Sahlgrenska, Göteborg University, Gothenburg, Sweden (C.S., J.H., J.W.). Antaros Medical , Molndal, Sweden AstraZeneca Mölndal Sweden Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska Academy Gothenburg University Gothenburg Sweden; AstraZeneca Mölndal Sweden From the Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska University Hospital/Sahlgrenska (O.W., J.H., J.W., C.S., G.B.), and the Department of Medical Chemistry, Göteborg University (S-O.O.), Gothenburg; and AstraZeneca (J.W.), Mölndal, Sweden. From The Wallenberg Laboratory for Cardiovascular Research (J.H.) and the Department of Medicine (L.B., B.F.), Sahlgrenska University Hospital, Göteborg University, Gothenburg, Sweden. From the Research Institute for Internal Medicine (T.U., C.D., P.A.), Section of Endocrinology (T.U.), Department of Cardiology (J.K., L.G.), and Section of Clinical Immunology and Infectious Diseases (P.A.), Rikshospitalet University Hospital, University of Oslo, Oslo, Norway; Wallenberg Laboratory for Cardiovascular Research (J.H., J.W.), Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden; AstraZeneca (M.L.), Mölndal, Sweden; Klinik für Innere Medizin III (M.B.), Universitätsklinikum... The Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska University Hospital, Sahlgrenska Academy, Göteborg University, Gothenburg, Sweden. johannes.hulthe@wlab.wall.gu.se Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska Academy at Göteborg University, Göteborg, Sweden. From AstraZeneca Cardiovascular R&D (P.D., J.H., G.C.), Mölndal, Sweden; and the Wallenberg Laboratory for Cardiovascular Research “Sahlgrenska Academy” (B.F., H.H., G.C.), Göteborg University, Sweden. From the Wallenberg Laboratory for Cardiovascular Research (J.H., J.W., O.W., I.W.) and the Division of Cardiology (H.E.), Sahlgrenska University Hospital, Göteborg University, Gothenburg, Sweden; and the Thorax Center, Erasmus University Dijkzigt Hospital, Rotterdam, The Netherlands (P.J. de F.). From The Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska University Hospital, Göteborg University, Gothenburg, Sweden. From the Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska University Hospital, Göteborg University, Gothenburg, Sweden Wallenberg Laboratory for Cardiovascular Research, and Center for Cardiovascular and Metabolic Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, AstraZeneca, Mölndal, Sweden Wallenberg Laboratory for Cardiovascular Research Sahlgrenska University Hospital Gothenburg SE‐413 45 Sweden From the Wallenberg Laboratory for Cardiovascular Research (J.H., J.W., A.L., I.W., O.W.), Sahlgrenska University Hospital, Göteborg University, Gothenburg, and the Center for Molecular Medicine (G.K.H.), Karolinska Hospital, Karolinska Institute, Stockholm, Sweden. Antaros Medical Mölndal Sweden Wallenberg Laboratory Sahlgrenska Hospital Göteborg Sweden; AstraZeneca R&D Mölndal Sweden From the Institute of Internal Medicine (K.W., L.B., B.F.) and the Wallenberg Laboratory for Cardiovascular Research (J.W., J.H., B.F.), Sahlgrenska University Hospital, Gothenburg University, Gothenburg, Sweden. From the Wallenberg Laboratory for Cardiovascular Research (J.H., J.W.) and the Department of Medicine (L.B., B.F.), Sahlgrenska University Hospital, Göteborg University, Gothenburg, Sweden. The Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska University Hospital, Goteborg, Sweden From the Institute of Medicine, Department of Molecular and Clinical Medicine (M.H., A.P.T.K., J. Herlitz, K.C.), Wallenberg Laboratory for Cardiovascular Research (O.W., L.M.H., J. Hulthe), and Department of Clinical Physiology (A.P., K.C.), Sahlgrenska Academy and Sahlgrenska University Hospital, Gothenburg, Sweden; AstraZeneca R&D, Mölndal, Sweden (J. Hulthe); and the Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden (K.C.). The Wallenberg Laboratory for Cardiovascular Research (Å.T., J.H., K.W., J.W., B.F.), S-413 45 Göteborg, Sweden; Medical Advisors at AstraZeneca (J.H., J.W.), S-431 83 Mölndal, Sweden Wallenberg laboratory Sahlgrenska University Hospital Gothenburg Sweden Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska University Hospital, Göteborg University, Gothenburg, Sweden From the Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska University Hospital, Göteborg University, Gothenburg, Sweden. Wallenberg Laboratory Sahlgrenska University Hospital Gothenburg Sweden; AstraZeneca R&D Mölndal Sweden |
Incoming Links
Total number of triples: 93.